October 24, 2018
326th Edition – October 23, 2018
BioHealth Innovation If you are having trouble viewing this email, please click here October 23,…
October 22, 2018
American Gene Technologies Granted FDA Orphan Drug Designation For Phenylketonuria | American Gene Technology
American Gene Technologies (AGT), a leading gene and cell therapy company in the discovery and…
October 22, 2018
United Therapeutics to Develop CollPlant Technologies for 3D Bioprinted Lung Transplants – GEN
United Therapeutics will license, develop, and commercialize CollPlant Holdings’ recombinant human collagen (rhCollagen) and BioInk…
October 22, 2018
REGENXBIO Announces Exclusive Worldwide License with Ultragenyx for the Treatment of CDKL5 Deficiency Disorder Using NAV Vectors
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative…
October 22, 2018
Competing for Kids’ Health – Maryland Today
Children benefit from little of the $156 billion annual U.S. market for medical devices, but…
October 22, 2018
TaiRx, Inc. and BioHealth Innovation, Inc. Form TaiRx US to Develop and Commercialize Therapeutics and Precision Medicine Diagnostics
TaiRx, Inc and BioHealth Innovation, Inc. (BHI) announced today the formation of TaiRx US, a…
October 22, 2018
A New Targeted Cancer Company To Watch
Jean Cui led the invention of Pfizer's Xalkori. Now she has her own company focusing…
October 22, 2018
Time to Reconsider Glycomimetics Inc (NASDAQ:GLYC) After Less Short Sellers? – WhatsOnThorold
Investors sentiment decreased to 1.37 in 2018 Q2. Its down 0.26, from 1.63 in 2018Q1.…
October 22, 2018
Viela Bio Announces Late-Breaking Abstract Acceptance for VIB4920, a Novel Engineered CD40L Antagonist, at the 2018 ACR/ARHP Annual Meeting
Viela Bio heads to the 2018 American College of Rheumatology / Association of Rheumatology for…